Milan Fiala

Dr. Milan Fiala

Integrative Biology and Physiology, University of California, 67-368 NPI, Los Angeles, CA 90095, USA
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MFMilan Fiala
Milan Fiala
PLPhilip T. Liu
Philip T. Liu
AEAraceli Espinosa-Jeffrey
Araceli Espinosa-Jeffrey
MRMark J. Rosenthal
Mark J. Rosenthal
GBGeorge Bernard
George Bernard
JCJohn Cashman
John Cashman
We have tested a hypothesis that the natural product curcuminoids, which has epidemiologic and experimental rationale for use in AD, may improve the innate immune system and increase amyloid-β (Aβ) clearance from the brain of patients with sporadic Alzheimer's disease (AD). Macrophages of a majority of AD patients do not transport Aβ into endosomes and lysosomes, and AD monocytes do not efficiently clear Aβ from the sections of AD brain, although they phagocytize bacteria. In contrast, macrophages of normal subjects transport Aβ to endosomes and lysosomes, and monocytes of these subjects clear Aβ in AD brain sections. Upon Aβ stimulation, mononuclear cells of normal subjects up-regulate the transcription of β-1,4-mannosyl-glycoprotein 4-β- N -acetylglucosaminyltransferase ( MGAT3 ) ( P < 0.001) and other genes, including Toll like receptors ( TLRs ), whereas mononuclear cells of AD patients generally down-regulate these genes. Defective phagocytosis of Aβ may be related to down-regulation of MGAT3 , as suggested by inhibition of phagocytosis by using MGAT3 siRNA and correlation analysis. Transcription of TLR3 , bditTLR4, TLR5 , bditTLR7, TLR8 , TLR9 , and TLR10 upon Aβ stimulation is severely depressed in mononuclear cells of AD patients in comparison to those of control subjects. In mononuclear cells of some AD patients, the curcuminoid compound bisdemethoxycurcumin may enhance defective phagocytosis of Aβ, the transcription of MGAT3 and TLRs, and the translation of TLR2–4. Thus, bisdemethoxycurcumin may correct immune defects of AD patients and provide a previously uncharacterized approach to AD immunotherapy.

1 July 2009 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
AMAva Masoumi
Ava Masoumi
BGBen Goldenson
Ben Goldenson
SGSenait Ghirmai
Senait Ghirmai
HAHripsime Avagyan
Hripsime Avagyan
JZJustin Zaghi
Justin Zaghi
MFMilan Fiala
Milan Fiala
Patients with Alzheimer's disease (AD) suffer from brain amyloidosis related to defective clearance of amyloid-β (Aβ) by the innate immune system. To improve the innate immune system of AD patients, we studied immune stimulation of macrophages by 1α,

1 January 2010 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
MFMilan Fiala
Milan Fiala
MCMadhuri Chattopadhay
Madhuri Chattopadhay
ACAntonio La Cava
Antonio La Cava
ETEric Tse
Eric Tse
GLGuanghao Liu
Guanghao Liu
MWMartina Wiedau-Pazos
Martina Wiedau-Pazos
The contribution of inflammation to neurodegenerative diseases is increasingly recognized, but the role of inflammation in sporadic amyotrophic lateral sclerosis (sALS) is not well understood and no animal model is available. We used enzyme-linked immunosorbent assays (ELISAs) to measure the cytokine interleukin-17A (IL-17A) in the serum of ALS patients (n = 32; 28 sporadic ALS (sALS) and 4 familial ALS (fALS)) and control subjects (n = 14; 10 healthy subjects and 4 with autoimmune disorders). IL-17A serum concentrations were 5767 ± 2700 pg/ml (mean ± SEM) in sALS patients and 937 ± 927 pg/ml in fALS patients in comparison to 7 ± 2 pg/ml in control subjects without autoimmune disorders (p = 0.008 ALS patients vs. control subjects by Mann-Whitney test). Sixty-four percent of patients and no control subjects had IL-17A serum concentrations > 50 pg/ml (p = 0.003 ALS patients vs. healthy subjects by Fisher's exact test). The spinal cords of sALS (n = 8), but not control subjects (n = 4), were infiltrated by interleukin-1β- (IL-1β-), and tumor necrosis factor-α-positive macrophages (co-localizing with neurons), IL-17A-positive CD8 cells, and IL-17A-positive mast cells. Mononuclear cells treated with aggregated forms of wild type superoxide dismutase-1 (SOD-1) showed induction of the cytokines IL-1β, interleukin-6 (IL-6), and interleukin-23 (IL-23) that may be responsible for induction of IL-17A. In a microarray analysis of 28,869 genes, stimulation of peripheral blood mononuclear cells by mutant superoxide dismutase-1 induced four-fold higher transcripts of interleukin-1α (IL-1α), IL-6, CCL20, matrix metallopeptidase 1, and tissue factor pathway inhibitor 2 in mononuclear cells of patients as compared to controls, whereas the anti-inflammatory cytokine interleukin-10 (IL-10) was increased in mononuclear cells of control subjects. Aggregated wild type SOD-1 in sALS neurons could induce in mononuclear cells the cytokines inducing chronic inflammation in sALS spinal cord, in particular IL-6 and IL-17A, damaging neurons. Immune modulation of chronic inflammation may be a new approach to sALS.

6 February 2013 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
MMMathew T. Mizwicki
Mathew T. Mizwicki
GLGuanghao Liu
Guanghao Liu
MFMilan Fiala
Milan Fiala
LMLarry Magpantay
Larry Magpantay
JSJames Sayre
James Sayre
DTDavid B. Teplow
David B. Teplow
As immune defects in amyloid-β (Aβ) phagocytosis and degradation underlie Aβ deposition and inflammation in Alzheimer's disease (AD) brain, better understanding of the relation between Aβ phagocytosis and inflammation could lead to promising preventi

13 January 2009 in Acta Neuropathologica
Verified
Journal Article
Open access
PDF file
JZJustin Zaghi
Justin Zaghi
BGBen Goldenson
Ben Goldenson
MIMohammed Inayathullah
Mohammed Inayathullah
ALAlbert S. Lossinsky
Albert S. Lossinsky
AMAva Masoumi
Ava Masoumi
MFMilan Fiala
Milan Fiala
Neuronal accumulation of oligomeric amyloid-β (Αβ) is considered the proximal cause of neuronal demise in Alzheimer disease (AD) patients. Blood-borne macrophages might reduce Aβ stress to neurons by immigration into the brain and phagocytosis of Αβ. We tested migration and export across a blood-brain barrier model, and phagocytosis and clearance of Αβ by AD and normal subjects’ macrophages. Both AD and normal macrophages were inhibited in Αβ export across the blood-brain barrier due to adherence of Aβ-engorged macrophages to the endothelial layer. In comparison to normal subjects’ macrophages, AD macrophages ingested and cleared less Αβ, and underwent apoptosis upon exposure to soluble, protofibrillar, or fibrillar Αβ. Confocal microscopy of stained AD brain sections revealed oligomeric Aβ in neurons and apoptotic macrophages, which surrounded and infiltrated congophilic microvessels, and fibrillar Aβ in plaques and microvessel walls. After incubation with AD brain sections, normal subjects’ monocytes intruded into neurons and uploaded oligomeric Aβ. In conclusion, in patients with AD, macrophages appear to shuttle Aβ from neurons to vessels where their apoptosis may release fibrillar Aβ, contributing to cerebral amyloid angiopathy.

6 July 2007 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
MFMilan Fiala
Milan Fiala
DCDavid H. Cribbs
David H. Cribbs
MRMark Rosenthal
Mark Rosenthal
GBGeorge Bernard
George Bernard
Innate immunity provides the first line of defense by recognizing pathogen-associated microbial patterns and inducing key co-stimulatory molecules and cytokines, which activate the mechanisms of the adaptive immune response. Innate immune cells perfo